𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical evaluation of gadodiamide injection in paediatric MR imaging

✍ Scribed by S. Hanquinet; C. Christophe; D. De Greef; P. Gordon; N. Perlmutter


Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
447 KB
Volume
26
Category
Article
ISSN
0301-0449

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Preliminary clinical trial of gadodiamid
✍ Gabriela D. Kaplan; Alex M. Aisen; S. Rao Aravapalli πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 685 KB

The safety and efficacy of a newly developed intravenous formulation of the nonionic contrast agent gadolinium diethylenetriaminepentaacetic acid-bis(methylamide), formulated as gadodiamide injection, was investigated. In 30 patients who underwent spin-echo magnetic resonance (MR) imaging before and

Clinical evaluation of aortic coarctatio
✍ Michael D. Hope; Alison K. Meadows; Thomas A. Hope; Karen G. Ordovas; David Salo πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 941 KB

## Abstract ## Purpose: To show that 4D Flow is a clinically viable tool for evaluation of collateral blood flow and demonstration of distorted blood flow patterns in patients with treated and untreated aortic coarctation. ## Materials and Methods: Time‐resolved, 3D phase contrast magnetic reson

Clinical evaluation of automated scan pr
✍ Frederic E. Lecouvet; JΓ©rΓ΄me Claus; Patrick Schmitz; Vincent Denolin; Clemens Bo πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 468 KB

## Abstract ## Purpose To compare an automated scan planning method to manual scan positioning in routine knee magnetic resonance imaging (MRI) studies. ## Materials and Methods The automated scan planning method uses anatomical landmarks in a 3D survey of the knee. The method is trained by exam

Comparison of the safety of the standard
✍ Marit G. Svaland; BjΓΈrg Lundby; Doris T. Kristoffersen πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 514 KB

## Abstract This study compared the safety and tolerability of gadodiamide injection at the standard dose (0.1 mmol/kg) and at a higher dose (0.3 mmol/kg) in 289 patients participating in a parallel group multiple independent trial program. All patients had a known or suspected central nervous syst